Cooperation between transcription factor AP-1 and NF-κB in the induction of interleukin-8 in human pancreatic adenocarcinoma cells by hypoxia

Journal of Interferon and Cytokine Research

Volumn 19, Issue 12, 1999, Pages 1363-1371

  Shi, Qian ^a   Le, Xiangdong ^a   Abbruzzese, James L ^a   Wang, Bailiang ^a   Mujaida, Naofumi ^b   Matsushima, Kouji ^b   Huang, Suyun ^a   Xiong, Qinghua ^a   Xie, Keping ^a,c  

^a UNIVERSITY OF TEXAS   (United States)

^b KANAZAWA UNIVERSITY   (Japan)

^c UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 8; MESSENGER RNA; TRANSCRIPTION FACTOR AP 1;

ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; HYPOXIA; PANCREAS ADENOCARCINOMA; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION;

ADENOCARCINOMA; BASE SEQUENCE; CELL HYPOXIA; DNA PRIMERS; HUMANS; INTERLEUKIN-8; NF-KAPPA B; PANCREATIC NEOPLASMS; RNA, MESSENGER; RNA, NEOPLASM; TRANS-ACTIVATION (GENETICS); TRANSCRIPTION FACTOR AP-1; UP-REGULATION;

EID: 0033403652     PISSN: 10799907     EISSN: None     Source Type: Journal    
DOI: 10.1089/107999099312821     Document Type: Article

References (69)

1. EVANS, D.B., ABBRUZZESE, J.L., and RICH, T.R. (1997). Cancer of the pancreas. In: Cancer Principles and Practice of Oncology, 5th ed. V.T. Devita, S. Hellman, and S.A. Rosenberg (eds.) Philadelphia: J.B. Lippincott, pp. 1054-1087.
2. KORC, M. (1998). Role of growth factors in pancreatic cancer. Surg. Oncol. Clin. North Am. 7, 25-41.
3. KERN, S.E. (1998). Advances from genetic clues in pancreatic cancer. Curr. Opin. Oncol. 10, 74-80.
4. SAITO, K., ISHIKURA, H., KISHIMOTO, T., KAWARADA, Y., YANO, T., TAKAHASHI, T., KATO, H., and YOSHIKI, T. (1998). Interleukin-6 produced by pancreatic carcinoma cells enhances humoral immune responses against tumor cells: a possible event in tumor regression. Int. J. Cancer 75, 284-289.
5. SMITH, D.R., POLVERINI, P.J., KUNKEL, S.L., ORRINGER, M.B., WHYTE, R.I., BURDICK, M.D., WILKE, C.A., and STRIETER, R.M. (1994). Inhibition of interleukin 8 attenuates angiogenesis in bronchogenic carcinoma. J. Exp. Med. 179, 1409-1415.
6. ARENBERG, D.A., KUNKEL, S.L., POLVERINI P.J., GLASS, M., BURDICK, M.D., and STRIETER, R.M. (1996). Inhibition of interleukin-8 reduces tumorigenesis of human non-small cell lung cancer in SCID mice. J. Clin. Invest. 97, 2792-2802.
7. BREW, R., SOUTHERN, S.A., FLANAGAN, B.F., McDICKEN, I.W., and CHRISTMAS, S.E. (1996). Detection of interleukin-8 mRNA and protein in human colorectal carcinoma cells. Eur. J. Cancer 32A, 2142-2147.
8. MILLER, L.J., KURTZMAN, S.H., WANG, Y., ANDERSON, K.H., LINDQUIST, R.R., and KREUTZER, D.L. (1998). Expression of interleukip-8 receptors on tumor cells and vascular endothelial cells in human breast cancer tissue. Anticancer Res. 18, 77-81.
9. YONEDA, J., KUNIYASU, H., CRISPENS, M.A., PRICE, J.E., BUCANA, C.D., and FIDLER, I.J. (1998). Expression of angiogenesis-related genes and progression of human ovarian carcinomas in nude mice. J. Natl. Cancer Inst. 90, 447-454.
10. SINGH, R.K., GUTMAN, M., RADINSKY, R., BUCANA, C.D., and FIDLER, I.J. (1994). Expression of interleukin 8 correlates with the metastatic potential of human melanoma cells in nude mice. Cancer Res. 54, 3242-3247.
11. GREENE, G.F., KITADAI, Y., PETTAWAY, C.A., VON ESCHENBACH, A.C., BUCANA, C.D., and FIDLER, I.J. (1997). Correlation of metastasis-related gene expression with metastatic potential in human prostate carcinoma cells implanted in nude mice using an in situ messenger RNA hybridization technique. Am. J. Pathol. 150, 1571-1582.
12. KITADAI, Y., HARUMA, K., SUMII, K., YAMAMOTO, S., UE, T., YOKOZAKI, H., YASUI, W., OHMOTO, Y., KAJIYAMA, G., FIDLER, I.J., and TAHARA, E. (1998). Expression of interleukin-8 correlates with vascularity in human gastric carcinomas. Am. J. Pathol. 152, 93-100.
13. SCHADENDORF, D., MOLLER, A., ALGERMISSEN, B., WORM, M., STICHERLING, M. and CZARNETZKI, B.M. (1993). IL-8 produced by human malignant melanoma cells in vitro is an essential autocrine growth factor. J. Immunol. 15, 2667-2675.
14. GALFFY, G., MOHAMMED, K.A., DOWLING, P.A., NASREEN, N., WARD, M.J., and ANTONY, V.B. (1999). Interleukin 8: an autocrine growth factor for malignant mesothelioma. Cancer Res. 59, 367-371.
15. NORGAUER, J., METZNER, B., and SCHRAUFSTATTER, I. (1996). Expression and growth-promoting function of the IL-8 receptor beta in human melanoma cells. J. Immunol. 156, 1132-1137.
16. YAMANAKA, R., TANAKA, R., YOSHIDA, S., SAITHOH, T., and FUJITA, K. (1995). Growth inhibition of human glioma cells modulated by retrovirus gene transfection with antisense IL-8. J. Neurooncol. 25, 59-65.
17. KOCH, A.E., POLVERINI, P.J., KUNKEL, S.L., HARLOW, L.A., DIPIETRO, L.A., ELNER, V.M., ELNER, S.G., and STRIETER, R.M. (1992). Interleukin-8 as a macrophage-derived mediator of angiogenesis. Science 258, 1798-1801.
18. STRIETER, R.M., KUNKE, LS.L., ELNER, V.M., MARTONYI, C.L., KOCH, A.E., POLVERINI, P.J., and ELNER, S.G. (1992). Interleukin-8. A corneal factor that induces neovascularization. Am. J. Pathol. 141, 1279-1284.
19. HU, D.E., HORI, Y., and FAN, T.P. (1993). Interleukin-8 stimulates angiogenesis in rats. Inflammation 17, 135-143.
20. NICKOLOFF, B.J., MITRA, R.S., VARANI, J., DIXIT, V.M., and POLVERINI, P.J. (1994). Aberrant production of interleukin-8 and thrombospondin-1 by psoriatic keratinocytes mediates angiogenesis. Am. J. Pathol. 144, 820-828.
21. SUNDERKOTTER, C., STEINBRINK, K., GOEBELER, M., BHARDWAJ, R., and SORG, C.J. (1994). Macrophages and angiogenesis. J. Leukocyte Biol. 55, 410-422.
22. PETZELBAUER, P., WATSON, C.A., PFAU, S.E., and POBER, J.S. (1995). IL-8 and angiogenesis: evidence that human endothelial cells lack receptors and do not respond to IL-8 in vitro. Cytokine 7, 267-272.
23. NORRBY, K. (1996). Interleukin-8 and de novo mammalian angiogenesis. Cell. Prolif. 29, 315-323.
24. ANTONY, V.B., HOTT, J.W., GODBEY, S.W., and HOLM, K. (1996). Angiogenesis in mesotheliomas. Role of mesothelial cell derived IL-8. Chest 109 (Suppl. 3), 21S-22S.
25. SHI, Q., ABRUZZESE, J.L., HUANG, S., FIDLER, I.J., XIONG, Q., and XIE, K. (1999). Constitutive and inducible interleukin-8 expression by hypoxia and acidosis renders human pancreatic cancer cells more tumorigenic and metastatic. Clin. Cancer Res. 5, 3105-3114.
26. MATSUSHIMA, K., and OPPENHEIM, J.J. (1989). Interleuken 8 and MCAF: novel inflammatory cytokines inducible by IL-1 and TNF. Cytokine 1, 2-13.
27. HERBERT, C.A., and BAKER, J.B. (1993). Interleukin-8: a review. Cancer Invest. 11, 743-750.
28. MUKAIDA, N., OKAMOTO, S., ISHIKAWA, Y., and MATSUSHIMA. K. (1994). Molecular mechanism of interleukin-8 gene expression. J. Leukocyte Biol. 56, 554-581.
29. BAGGIOLINI, M., LOETSCHER, P., and MOSER, B. (1995). Interleukin-8 and the chemokine family. Int. J. Immunopharmacol. 17, 103-108.
30. BAR-ELI, M. (1999). Role of interleukin-8 in tumor growth and metastasis of human melanoma. Pathobiology 67, 12-18.
31. FOLKMAN, J. (1996). Tumor angiogenesis and tissue factor. Nat. Med. 2, 167-168.
32. VAUPEL, P., KALLINOWSKI, F., and OKUNIEFF, P. (1989). Blood flow, oxygen and mutrient supply, and metabolic microenvironment of human tumors: a review. Cancer Rev. 49, 6449-6465.
33. 2 gradients in solid tumors in vivo: high-resolution measurements reveal a lack of correlation. Nat. Med. 3, 177-182.
34. TANNOCK, I.F. (1996). Treatment of cancer with radiation and drugs. J. Clin. Oncol. 14, 3156-3174.
35. BROWN, L.F., DETMAR, K., CLAFFEY, J.A., NAGY, D., FENG, A.M., DVORAK, A.M., and DVORAK, H.F. (1997). Vascular permeability factor/vascular endothelial growth factor: a multifunctional angiogenic cytokine. In: Regulation of Angiogenesis. I.D. Goldberg and E.M. Rosen (eds) Switzerland: Birkhauser Verlag Basel, pp. 233-270.
36. VAN MEIR, E., CESKA, M., EFFENBERGER, F., WALZ, A., GROUZMANN, E., DESBAILLETS, I., FREI, K., FONTANA, A., and DE TRIBOLET, N. (1992). Interleukin-8 is produced in neoplastic and infectious diseases of the human central nervous system. Cancer Res. 52, 4297-4305.
37. DESBAILLETS, I., DISERENS, A.C., TRIBOLET, N., HAMOU, M.F., and VAN MEIR, E.G. (1997). Upregulation of interleukin 8 by oxygen-deprived cells in glioblastoma suggests a role in leukocyte activation, chemotaxis, and angiogenesis. J. Exp. Med. 186, 1201-1212.
38. VEZERIDIS, M.P., MEITNER, P.A., TIBBETTS, L.M., DOREMUS, C.M., TZANAKAKIS, G., and CALABRESI, P. (1990). Heterogeneity of potential for hematogenous metastasis in a human pancreatic carcinoma. J. Surg. Res. 48, 51-55.
39. KUMAR, R., DONG, Z., and FIDLER, I.J. (1996). Differential regulation of metalloelastase activity in murine peritoneal macrophages by granulocyte-macrophage colony-stimulating factor and macrophage colony-stimulating factor. J. Immunol. 157, 5104-5111.
40. HUANG, S., JEAN, D., LUCA, M., TAINSKY, M.A., and BARELI, M. (1998). Loss of AP-2 results in downregulation of c-KIT and enhancement of melanoma tumorigenicity and metastasis. EMBO J. 17, 4358-4369.
41. GUTMAN, M., SINGH, R.K., XIE, K., BUCANA, C.D., and FIDLER, I.J. (1995). Regulation of interleukin-8 expression in human melanoma cells by the organ environment. Cancer Res. 55, 2470-2475.
42. VAUPEL, P. (1997). Vascularization, blood flow, oxygenation, tissue pH, and bioenergetic status of human breast cancer. Adv. Exp. Med. Biol. 411, 243-254.
43. 2 gradients in solid tumors in vivo: high-resolution measurements reveal a lack of correlation. Nat. Med. 3, 177-182.
44. TANNOCK, I.F. (1996). Treatment of cancer with radiation and drugs. J. Clin. Oncol. 14, 3156-3174.
45. KARAKURUM, M., SHREENIWAS, R., CHEN, J., PINSKY, D., YAN, S.D., ANDERSON, M., SUNOUCHI, K., MAJOR, J., HAMILTON, T., and KUWABARA, K. (1994). Hypoxic induction of interleukin-8 gene expression in human endothelial cells. J. Clin. Invest. 93, 1564-1570.
46. METINKO, A.P., KUNKEL, S.L., STANDIFORD, T.J., and STRIETER, R.M. (1992). Anoxia-hyperoxia induces monocyte-derived interleukin-8. J. Clin. Invest. 90, 791-798.
47. LUCA, M., HUANG, S., GERSHENWALD, J.E., SINGH, R.K., REICH, R., and BAR-ELI, M. (1997). Expression of interleukin-8 by human melanoma cells up-regulates MMP-2 activity and increases tumor growth and metastasis. Am. J. Pathol. 151, 1105-1113.
48. SCHMIELAU, J., KALTHOFF, H., ROEDER, C., and SCHMIEGEL, W. (1996). The role of cytokines in pancreatic cancer. Int. J. Pancreatol. 19, 157-163.
49. STRIETER, R.M., STANDIFORD, T., CHENSUE, S.W., KASAHARA, K., and KUNKEL, S.L. (1991). Induction and regulation of interleukin-8 gene expression. Adv. Exp. Med. Biol. 305, 23-30.
50. OKAMOTO, S., MUKAIDA, N., YASUMOTO, K., HORIGUCHI, H., and MATSUSHIMA, K. (1993). Molecular mechanism of interleukin-8 gene expression. Adv. Exp. Med. Biol. 351, 87-97.
51. VILARETE, L.H., and REMICK, D.G. (1996). Transcriptional and post-transcriptional regulation of interleukin-8. Am. J. Pathol. 149, 1685-1693.
52. FORSYTHE, J.A., JIANG, B.H., IYER, N.V., AGANI, F., LEUNG, S.W., KOOS, R.D., and SEMENZA, G.L. (1996). Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1. Mol. Cell Biol. 16, 4604-4613.
53. CLAFFEY, K.P., SHIH, S.C., MULLEN, A., DZIENNIS, S., CUSICK, J.L., ABRAMS, K.R., LEE, S.W., and DETMAR, M. (1998). Identification of a human VPF/VEGF 3′ untranslated region mediating hypoxia-induced mRNA stability. Mol. Biol. Cell. 9, 469-481.
54. 2-responsive sequences on the tyrosine hydroxylase gene. J. Biol. Chem. 270, 23774-23779.
55. PAULDING, W.R., and CZYZYK-KRZESKA, M.F. (1999). Regulation of tyrosine hydroxylase mRNA stability by protein-binding, pyrimidine-rich sequence in the 3′-untranslated region. J. Biol. Chem. 274, 2532-2538.
56. MELILLO, G., MUSSO, T., SICA, A., TAYLOR, L.S., COX, G.W., and VARESIO, L. (1995). A hypoxia-responsive element mediates a novel pathway of activation of the inducible nitric oxide synthase promoter. J. Exp. Med. 182, 1683-1693.
57. ARCHER, S.L., FREUDE, K.A., and SHULTZ, P.J. (1995). Effect of graded hypoxia on the induction and function of inducible nitric oxide synthase in rat mesangial cells. Circ. Res. 77 21-28.
58. MAXWELL, P., and RATCLIFFE, P. (1998). Regulation of expression of the erythropoietin gene. Curr. Opin. Hematol. 3 166-170.
59. YASUMOTO, K., OKAMOTO, S., MUKAIDA, N., MURAKAMI, S., MAI, M., and MATSUSHIMA, K. (1992). Tumor necrosis factor alpha and interferon gamma synergistically induce interleukin 8 production in a human gastric cancer cell line through acting concurrently on AP-1 and NF-κB-like binding sites of the interleukin 8 gene. J. Biol. Chem. 267, 22506-22511.
60. LEE, L.F., HASKILL, J.S., MUKAIDA, N., MATUSUHIMA, K., and TING, J.P. (1997). Identification of tumor-specific paclitaxel (Taxol)-responsive regulatory elements in the interleukin-8 promotor. Mol. Cell. Biol. 17, 5097-5105.
61. MORI, N., MUKAIDA, N., BALLARD, D.W., MATSUSHIMA, K., and YAMAMOTO, N. (1998). Human T-cell leukemia virus type I Tax transactivates human interleukin 8 gene through acting concurrently on AP-1 and nuclear factor-kappaB-like sites. Cancer Res. 58, 3993-4000.
62. MURAYAMA, T., OHARA, Y., OBUCHI, M., KHABAR, K.S., HIGASHI, H., MUKAIDA, N., and MATSUSHIMA, K. (1997). Human cytomegalovirus induces interleukin-8 production by a human monocytic cell line, THP-1. through acting concurrently on AP-1- and NF-kappaB-binding sites of the interleukin-8 gene. J. Virol. 71, 5692-5695.
63. KOONG, A.C., CHEN, E.Y., and GIACCIA, A.J. (1994). Hypoxia causes the activation of nuclear factor kappa B through the phosphorylation of I kappa B alpha on tyrosine residues. Cancer Res. 54, 1425-1430.
64. YAO, K.S., XANTHOUDAKIS, S., CURRAN, T., and O'DWYER, P.J. (1994). Activation of AP-1 and of a nuclear redox factor, Ref-1, in the response of HT29 colon cancer cells to hypoxia. Mol. Cell. Biol. 14, 5997-6003.
65. LADEROUTE, K.R., MENDONCA, H.L., CALAOAGAN, J.M., KNAPP, A.M., GIACCIA, A.J., and STORK, P.J. (1999). Mitogen-activated protein kinase phosphatase-1 (MKP-1) expression is induced by low oxygen conditions found in solid tumor microenvironments. A candidate MKP for the inactivation of hypoxia-inducible stress-activated protein kinase/c-Jun N-terminal protein kinase activity. J. Biol. Chem. 274, 12890-12897.
66. SMEAL, T., ANGEL, P., MEEK, J., and KARIN, M. (1989). Different requirements for formation of Jun:Jun and Jun:Fos complexes. Genes Dev. 3, 2091-2100.
67. RUPEC, R.A., and BAEUERLE, P.A. (1995). The genomic response of tumor cells to hypoxia and reoxygenation. Differential activation of transcription factors AP-1 and NF-kappa B. Eur. J. Biochem. 234, 632-640.
68. WEBSTER, K.A., DISCHER, D.J., and BISHOPRIC, N.H. (1993). Induction and nuclear accumulation of fos and jun proto-oncogenes in hypoxic cardiac myocytes. J. Biol. Chem. 268, 16852-16858.
69. BANDYOPADHYAY, R.S., PHELAN, M., and FALLER, D.V. (1995). Hypoxia induces AP-1-regulated genes and AP-1 transcription factor binding in human endothelial and other cell types. Biochim. Biophys. Acta 1264, 72-78.